» Articles » PMID: 15579791

Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) Genes Predict the Conversion from Impaired Glucose Tolerance to Type 2 Diabetes. The Finnish Diabetes Prevention Study

Overview
Specialty Endocrinology
Date 2004 Dec 8
PMID 15579791
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes is caused by defective insulin secretion and impaired insulin action. We investigated whether common polymorphisms in the SUR1 and Kir6.2 genes are associated with increased risk of type 2 diabetes in 490 subjects with impaired glucose tolerance participating in the Finnish Diabetes Prevention Study. The 1273AGA allele of the SUR1 gene was associated with a 2-fold risk of type 2 diabetes [odds ratio (OR), 2.00; 95% confidence interval (CI), 1.19-3.36; P = 0.009]. This silent polymorphism was in linkage disequilibrium with three promoter polymorphisms (G-2886A, G-1561A, and A-1273G), and they formed a high-risk haplotype having a 2-fold risk of type 2 diabetes (OR, 1.89; 95% CI, 1.09-3.27; P = 0.023). Subjects with both the high-risk haplotype of the SUR1 gene and the 23K allele of the Kir6.2 gene had a 6-fold risk for the conversion to diabetes compared with those without any of these risk genotypes (OR, 5.68; 95% CI, 1.75-18.32; P = 0.004). We conclude that the polymorphisms of the SUR1 gene predicted the conversion from impaired glucose tolerance to type 2 diabetes and that the effect of these polymorphisms on diabetes risk was additive with the E23K polymorphism of the Kir6.2 gene.

Citing Articles

Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy.

Mota-Zamorano S, Gonzalez L, Robles N, Valdivielso J, Arevalo-Lorido J, Lopez-Gomez J Ann Med. 2022; 54(1):3039-3051.

PMID: 36314849 PMC: 9635471. DOI: 10.1080/07853890.2022.2138531.


SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.

Gurzeler E, Ruotsalainen A, Laine A, Valkama T, Kettunen S, Laakso M PLoS One. 2021; 16(11):e0258408.

PMID: 34767557 PMC: 8589160. DOI: 10.1371/journal.pone.0258408.


Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population.

Engwa G, Nwalo F, Chikezie C, Onyia C, Ojo O, Mbacham W BMC Med Genet. 2018; 19(1):78.

PMID: 29751826 PMC: 5948806. DOI: 10.1186/s12881-018-0601-1.


Precision medicine in diabetes prevention, classification and management.

Xie F, Chan J, Ma R J Diabetes Investig. 2018; 9(5):998-1015.

PMID: 29499103 PMC: 6123056. DOI: 10.1111/jdi.12830.


ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.

Chowdhury U, Dosa P, Fautsch M Exp Eye Res. 2016; 158:85-93.

PMID: 27130546 PMC: 5081279. DOI: 10.1016/j.exer.2016.04.020.